Open Access

Oral anticoagulation – Managing challenging patients with NVAF.


Topic: Atrial fibrillation (AF)
Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Congress Presentation

About the speaker

Professor Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)
11 presentations
0 follower

5 more presentations in this session

Improving patient care with NOACs – Where are we now?

Speaker: Professor F. Andreotti (Rome, IT)


Thrombosis versus bleeding risk in NVAF patients – From trials to clinical practice.

Speaker: Professor G. Lip (Liverpool, GB)


Can evidence from VTE treatment trials with NOACs inform the cardiologist?

Speaker: Doctor A. Cohen (London, GB)


Are there more NVAF patients that would benefit from anticoagulation with a NOAC?

Speaker: Professor J. Healey (Hamilton, CA)


Optimising patient care with NOACs – Panel discussion.

Speaker: Professor H. Darius (Berlin, DE) Professor F. Andreotti (Rome, IT)


Access the full session

Oral anticoagulation, thrombosis and bleeding – Improving patient care with NOACs

Speakers: Professor H. Darius, Professor F. Andreotti, Professor G. Lip, Doctor A. Cohen, Professor J. Healey...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb